BIOCRYST PHARMACEUTICALS INC Earnings Per Share, Basic in USD/shares from Q2 2014 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Biocryst Pharmaceuticals Inc quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2014 to Q3 2025.
  • Biocryst Pharmaceuticals Inc Earnings Per Share, Basic for the quarter ending September 30, 2025 was 0.06 USD/shares.
  • Biocryst Pharmaceuticals Inc Earnings Per Share, Basic for the twelve months ending September 30, 2025 was 0 USD/shares, a 91.8% increase year-over-year.
  • Biocryst Pharmaceuticals Inc annual Earnings Per Share, Basic for 2024 was -0.43 USD/shares, a 63.6% increase from 2023.
  • Biocryst Pharmaceuticals Inc annual Earnings Per Share, Basic for 2023 was -1.18 USD/shares, a 11.3% increase from 2022.
  • Biocryst Pharmaceuticals Inc annual Earnings Per Share, Basic for 2022 was -1.33 USD/shares, a 29.1% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

BIOCRYST PHARMACEUTICALS INC Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $0 $0.06 +$0.13 Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-04
Q2 2025 $0 $0.02 +$0.08 Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-05
Q1 2025 $0 $0 +$0.17 Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 $0 $0 +$0.18 +58.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-25
Q3 2024 $0 $0 +$0.12 +63.2% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-04
Q2 2024 $0 $0 +$0.34 +85% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-05
Q1 2024 -$1 $0 +$0.11 +39.3% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q4 2023 -$1 $0 +$0.07 +18.4% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-25
Q3 2023 -$1 $0 +$0.04 +17.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 -$1 $0 $0 -25% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$1 $0 +$0.12 +30% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$1 $0 $0 -280% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-25
Q3 2022 -$1 $0 +$0.10 +30.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$1 $0 $0 -33.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$1 $0 $0 -11.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$1 $0 Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q2 2016 $0 $0 -414% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-08
Q4 2015 $0 $0 Oct 1, 2015 Dec 31, 2015 10-K 2017-02-27
Q3 2015 $0 Jul 1, 2015 Sep 30, 2015 10-K 2017-02-27
Q2 2015 $0.07 +$0.30 Apr 1, 2015 Jun 30, 2015 10-K 2017-02-27
Q1 2015 $0 Jan 1, 2015 Mar 31, 2015 10-K 2017-02-27
Q2 2014 $0 Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07

BIOCRYST PHARMACEUTICALS INC Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $0 +$0.75 +63.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-25
2023 -$1 +$0.15 +11.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-25
2022 -$1 $0 -29.1% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-25
2021 -$1 +$0.06 +5.51% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$1 Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.